Research
Hormonal
High intake of sugar-sweetened beverages, particularly those containing high fructose corn syrup, increases the risk of developing type 2 diabetes mellitus (T2DM) and obesity by raising blood glucose levels and BMI.
Avoid sugar-sweetened beverages, including those with high fructose corn syrup, as they directly raise blood glucose and BMI, increasing T2DM risk. Be aware that diet soft drinks may also negatively impact insulin resistance due to glycated chemicals, so water or unsweetened alternatives are safer choices for metabolic health.
ModerateSupportsMEDIUM confidence
Recently, evidence suggested a link between the intake of soft drinks with obesity and diabetes, resulting from large amounts of high fructose corn syrup used in the manufacturing of soft drinks, which raises blood glucose levels and BMI to the dangerous levels.
Why this rating
The paper is a review citing multiple observational and prospective studies (e.g., Ludwig et al., Assy et al.), but lacks a single definitive RCT in the text.
Source
Effect of diet on type 2 diabetes mellitus: A review.
Waqas Sami et al. · PubMed · 2017
narrative_reviewCited 225×
Read the paper More from this paper
- High intake of red meat, sweets, and fried foods increases the risk of insulin resistance and type 2 diabetes, whereas consumption of fruits and vegetables is inversely correlated with T2DM risk.Moderate
- Adherence to a Mediterranean-style dietary pattern, characterized by high intake of fruits, vegetables, fish, and olive oil, is associated with improved glucose metabolism and a decreased risk of type 2 diabetes and cardiovascular disease.Moderate
- High intake of white rice is associated with an increased risk of type 2 diabetes mellitus, particularly in certain populations such as Japanese women.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →